Philippe Parola

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · International Journal of Antimicrobial Agents · 2020 · 4.9K citations · Full text

Covid-19 Pandemic, Antiviral Therapy, Antiviral Drug +4

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · 2020 · 1.1K citations · Full text

Viral Load, Antibiotics, Respiratory Diseases +13

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study

Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · Travel Medicine and Infectious Disease · 2020 · 780 citations · Full text

Long Covid, Antibiotics, Microbiological Effect +9

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France

Matthieu Million, Jean‐Christophe Lagier, Philippe Gautret et al. · Travel Medicine and Infectious Disease · 2020 · 486 citations · Full text

Antibiotics, Clinical Infectious Disease, Healthcare-associated Infection +7

Guidelines for the diagnosis of tick-borne bacterial diseases in Europe

Philippe Brouqui, F. Bacellar, G. Baranton et al. · Clinical Microbiology and Infection · 2004 · 410 citations

Vector-borne Pathogen, Epidemiology, Diagnosis +8